© 1984 Oxford University Press
research-article |
Naphthalene Toxicity in CD-1 Mice: General Toxicology and Immunotoxicology
*Department of Pharmacology and Toxicology, Medical College of Virginia Richmond, Virginia 23298
Department of Pharmacology, School of Medicine, East Carolina University Greenville, North Carolina 27834
Environmental Protection Agency 26 West St. Clair Street, Cincinnati, Ohio 45268
Naphthalene Toxicity in CD-1 Mice: General Toxicology and Immunotoxicology. SHOPP, G. M., WHITE, K. L., JR., HOLSAPPLE, M. P., BARNES, D. W., DUKE, S. S., ANDERSON, A. C., CONDIE, L. W., JR., HAYES, J. R., AND BORZELLECA, J. F. (1984). Fundam. Appl. Toxicology. 4, 406–419. Random bred CD-1 mice were used to evaluate the acute oral toxicity and subchronic toxicity of naphthalene administered in corn oil. The acute oral LD50 of naphthalene was 533 and 710 mg/kg in male and female mice, respectively. Subchronic toxicity was evaluated with 14- and 90-day daily oral gavage studies. Doses utilized in the 14-day study were 27, 53, and 267 mg/kg, with the latter representing one-half of the male LD50. Both males and females demonstrated a 5–10% mortality and depressed body weight at the high dose only. Males had decreased thymus weights, and females had decreased spleen and increased lung weights at the high dose only. Other organ weights were unaffected at any dosage level. Serum enzyme and electrolyte levels were not altered in a dose-related manner. To assess the potential immunotoxicity of naphthalene the following screen was utilized: humoral immune response, response to mitogens, delayed hypersensitivity response, popliteal lymph node response, bone marrow stem cell number, and DNA synthesis. No evidence of immunotoxicity was demonstrated. The 90-day study employed daily oral doses of 5.3, 53, and 133 mg/kg. There was no treatment-related mortality in either sex, nor was body weight affected. Organ weights were not affected in males, and females showed reduced spleen weights only at the high dose. Serum enzyme and electrolyte levels, as well as the immunotoxicity screen, indicated that naphthalene doses up to one-fourth the LD50 for 90 days failed to elicit consistent statistically significant and biologically relevant compound-related effects. A screen of the effects of the 90-day naphthalene treatment on various aspects of the hepatic drug metabolizing system indicated no alterations, with the exception of a specific dose-related inhibition of aryl hydrocarbon hydroxylase activity in both male and female mice.